A drug that can slow the effects of spinal muscular atrophy is approved for use on the NHS.

Source

Findings from thousands of UK people suggest a possible benefit, although more studies are needed.

Source

Research indicates 30% of areas have no residential care home beds and 60% no nursing home beds.

Source